NBTX

Q: What is the price of Nanobiotix (NBTX) today?

The current price of Nanobiotix (NBTX) is $38.50. The stock began the year trading around $23.12 and is currently priced at $38.50. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Nanobiotix (NBTX) pay dividends?

Nanobiotix (NBTX) did not pay dividends over the past year.

Q: Is Nanobiotix (NBTX) a good investment?

Nanobiotix (NBTX) is currently trading at $38.50 with a P/E ratio of -18.49. This represents a -589% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 690.53%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Nanobiotix S.A.

Price

$38.50

return (12m)

690.53%

p/e

-18.49

p/bv

-18.68

DIVIDEND YIELD

0.00%

NBTX price

Nanobiotix

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment NBTX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

3.21%

3 months

24.03%

1 year

690.53%

2 years

613.61%

5 years

168.47%

10 years

0.00%

Fundamentals NBTX

review the fundamentals of Nanobiotix shares

P/E

-18.49

Sector: -4.19 Industry: -4.19

P/S (PSR)

82.90

Sector: -4.12 Industry: -4.12

P/BV

-18.68

Sector: 2.03 Industry: 2.03

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-125.96%

Sector: -66.67% Industry: -66.67%

ROE

101.02%

Sector: -66.75% Industry: -66.75%

ROIC

-49.05%

Sector: -2,914.97% Industry: -2,914.97%

NET MARGIN

-100.00%

Sector: -40.34% Industry: -40.34%

GROSS MARGIN

100.00%

Sector: 36.53% Industry: 36.53%

OPERATING MARGIN

-100.00%

Sector: -39.20% Industry: -39.20%

EV/EBITDA

-24.41

Sector: -4.32 Industry: -4.32

EV/EBIT

-23.35

Sector: -4.40 Industry: -4.40

PRICE-TO-ASSETS

23.29

Sector: 1.47 Industry: 1.47

BVPS

-2.06

Sector: 1.86 Industry: 1.86

EPS

-2.08

Sector: -2.18 Industry: -2.18

EQUITY-TO-ASSETS RATIO

-1.25

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

2.25

Sector: 0.39 Industry: 0.39

CAGR REVENUE 5 YEARS

5,502.58%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

1,214.64%

Sector: - Industry: -

Fundamentals NBTX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
NBTX	-18.49	-18.68	101.02%	0.00%	$1.85 B	-100.00%
JNJ	30.12	7.81	25.92%	1.99%	$633.66 B	21.83%
PFE	18.48	1.53	8.29%	7.07%	$138.41 B	11.83%
ABBV	127.12	-69.89	-54.98%	2.58%	$462.09 B	5.79%
NVO	11.81	7.13	60.40%	3.69%	$224.06 B	37.15%
MRK	35.84	6.97	19.45%	2.56%	$320.27 B	13.59%
AZN	29.10	6.38	21.93%	1.64%	$302.29 B	17.19%
GILD	17.69	6.96	39.33%	2.45%	$163.04 B	30.99%
BMY	16.28	5.89	36.19%	4.30%	$118.47 B	15.01%
ZTS	11.94	9.76	81.75%	2.75%	$31.57 B	27.79%
REGN	15.38	2.17	14.08%	0.56%	$68.04 B	29.65%
HALO	26.88	42.68	158.82%	0.00%	$9.38 B	23.13%
AMGN	25.90	21.98	84.87%	2.62%	$202.04 B	20.96%
MCK	20.14	-115.02	-570.98%	0.42%	$95.93 B	1.18%
VRTX	30.92	6.93	22.41%	0.00%	$134.12 B	35.51%
CAH	36.11	-21.01	-58.20%	0.85%	$56.15 B	0.62%
HRMY	14.84	2.37	16.00%	0.00%	$2.16 B	16.20%
BIIB	23.16	1.70	7.36%	0.00%	$31.77 B	13.81%
MEDP	33.91	26.09	76.95%	0.00%	$15.61 B	17.19%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

NBTX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Nanobiotix

Nanobiotix S.A.

Average Investor10 user rating

4.0 (2 people)

United States

23 years

Founded: 2003

2020

Time since IPO - 6 years

88

Employees

Nanobiotix S.A. (United States) is listed on the Nasdaq and has a market capitalization of $1.85 billion, with shareholders equity totaling $-98.93 million.

The company employs approximately 88 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Nanobiotix S.A. reported $22.29 million in revenue, generating net income of $-99.94 million.

Key financial metrics include a P/E ratio of -18.49, a price-to-book (P/B) ratio of -18.68, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker NBTX.

Market cap

$1.85 billion

Net worth

$-98.93 million

$-98,930,000.00

Assets

$79.34 million

$79,340,000.00

Total Shares Outstanding

48.00 million

48,000,000

Average Daily Trading Volume

$82.70 Thousand

$82,703.10

Sector

Health Care

Industry

Biotechnology

NBTX

NBTX revenue and profits

Financial Results NBTX

DRAG THE FRAME TO SEE MORE DATA

NBTX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$786.30 9,76% (12M)

P/E

20.14

0.42%

ROE

-570.98%

P/BV

-115.02

CAH - Cardinal Health

$238.94 46,53% (12M)

P/E

36.11

0.85%

ROE

-58.20%

P/BV

-21.01

JNJ - Johnson & Johnson

$263.04 72,84% (12M)

P/E

30.12

1.99%

ROE

25.92%

P/BV

7.81

MRK - Merck & Co.

$129.56 65,87% (12M)

P/E

35.84

2.56%

ROE

19.45%

P/BV

6.97

AZN - AstraZeneca

$195.15 42,59% (12M)

P/E

29.10

1.64%

ROE

21.93%

P/BV

6.38

ABBV - AbbVie

$261.07 43,55% (12M)

P/E

127.12

2.58%

ROE

-54.98%

P/BV

-69.89

NVO - Novo Nordisk

$50.43 --23,73% (12M)

P/E

11.81

3.69%

ROE

60.40%

P/BV

7.13

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$786.30 9,76% (12 M)

P/L

20.14

0.42%

ROE

-570.98%

P/VP

-115.02

CAH - Cardinal Health

$238.94 46,53% (12 M)

P/L

36.11

0.85%

ROE

-58.20%

P/VP

-21.01

JNJ - Johnson & Johnson

$263.04 72,84% (12 M)

P/L

30.12

1.99%

ROE

25.92%

P/VP

7.81

MRK - Merck & Co.

$129.56 65,87% (12 M)

P/L

35.84

2.56%

ROE

19.45%

P/VP

6.97

AZN - AstraZeneca

$195.15 42,59% (12 M)

P/L

29.10

1.64%

ROE

21.93%

P/VP

6.38

ABBV - AbbVie

$261.07 43,55% (12 M)

P/L

127.12

2.58%

ROE

-54.98%

P/VP

-69.89

NVO - Novo Nordisk

$50.43 --23,73% (12 M)

P/L

11.81

3.69%

ROE

60.40%

P/VP

7.13

Frequently Asked Questions

What is the price of Nanobiotix (NBTX) today?

The current price of Nanobiotix (NBTX) is $38.50. The stock began the year trading around $23.12 and is currently priced at $38.50. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Nanobiotix (NBTX) pay dividends?

Nanobiotix (NBTX) did not pay dividends over the past year.

Is Nanobiotix (NBTX) a good investment?

Nanobiotix (NBTX) is currently trading at $38.50 with a P/E ratio of -18.49. This represents a -589% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 690.53%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Nanobiotix (NBTX) stock?

You can buy Nanobiotix (NBTX) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol NBTX and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Nanobiotix (NBTX) yield today?

Over the past month, Nanobiotix (NBTX) has returned 3.21% — 690.53% over the past year, and 168.47% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Nanobiotix (NBTX) today at the current price of $38.50 your total investment would be $3,849.90.

Based on historical performance, the investment would have grown to approximately:

$30,434.61 after 1 year
$10,335.83 after 5 years
$3,849.90 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

NBTX

Nanobiotix S.A.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment NBTX

review the fundamentals of Nanobiotix shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Nanobiotix

Nanobiotix S.A.

United States

23 years

2020

88

PROFIT X PRICE NBTX

Financial Results NBTX

NBTX cash flow

Asset, Revenue and Profit Growth - NBTX

NBTX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

Frequently Asked Questions